NanoRepro AG (FRA:NN6) Accounts Payable: €0.15 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NN6 NanoRepro AG FRA:NN6
53 GF Score
Price €2.10
GF Value €0.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NanoRepro AG Accounts Payable?

NanoRepro AG FRA:NN6 53 Accounts Payable is €0.15 Mil as of Jun. 2025. GuruFocus rates FRA:NN6 with a GF Score™ of 53/100 and a GF Value™ of €0.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

NanoRepro AG's Accounts Payable for the quarter that ended in Jun. 2025 was €0.15 Mil.

NanoRepro AG's quarterly Accounts Payable declined from Jun. 2024 (€0.31 Mil) to Dec. 2024 (€0.22 Mil) and declined from Dec. 2024 (€0.22 Mil) to Jun. 2025 (€0.15 Mil).

NanoRepro AG's annual Accounts Payable declined from Dec. 2022 (€0.37 Mil) to Dec. 2023 (€0.17 Mil) but then increased from Dec. 2023 (€0.17 Mil) to Dec. 2024 (€0.22 Mil).

NanoRepro AG Accounts Payable Historical Data

* Premium members only.

The historical data trend for NanoRepro AG's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Accounts Payable Chart

NanoRepro AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 1.99 0.37 0.17 0.22

NanoRepro AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.31 0.22 0.15
FRA:NN6
53GF Score
NanoRepro AG FRA:NN6
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NanoRepro AG Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.15 Mil mean?
NanoRepro AG (FRA:NN6) has a Accounts Payable of €0.15 Mil as of Jun. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on NanoRepro AG and its competitors.
Is NanoRepro AG's Accounts Payable too high?
NanoRepro AG's current Accounts Payable is €0.15 Mil. Overall, NanoRepro AG has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Accounts Payable compare to TMO and DHR?
NanoRepro AG's Accounts Payable of €0.15 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on NanoRepro AG and its competitors. NanoRepro AG's current Accounts Payable is €0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (FRA:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.99, compared to a current price of €2.10 — trading 112.1% above its estimated fair value. The current Accounts Payable is €0.15 Mil. NanoRepro AG's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For NanoRepro AG (FRA:NN6), the current Accounts Payable is €0.15 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NanoRepro AG (FRA:NN6) Overvalued in 2026?

Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued. The current stock price of €2.10 is trading 112.1% above its estimated GF Value™ of €0.99. GuruFocus considers NanoRepro AG to be Significantly Overvalued.

Key valuation signals for FRA:NN6:

  • Accounts Payable: €0.15 Mil
  • GF Value™: €0.99 vs. price of €2.10 (112.1% above fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the FRA:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NanoRepro AG Business Description

Other Exchanges NN6:Germany
Address Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
53GF Score

Get the complete analysis for FRA:NN6

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price
€0.99
GF Value